Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: A meta-analysis

Diabetes Care

Volumn 29, Issue 9, 2006, Pages 2130-2136

  Kirk, Julienne K ^a   D'Agostino Jr , Ralph B ^a   Bell, Ronny A ^a   Passmore, Leah V ^a   Bonds, Denise E ^a   Karter, Andrew J ^b   Narayan, K M Venkat ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; CLINICAL TRIAL; DEMOGRAPHY; DIABETES MELLITUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; RACE DIFFERENCE; REVIEW; SYSTEMATIC REVIEW; AFRICAN AMERICAN; AGED; BLOOD; CAUCASIAN; ETHNOLOGY; INFORMATION SYSTEM; MIDDLE AGED; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; AGED; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFORMATION SYSTEMS; MIDDLE AGED; UNITED STATES;

EID: 33845342215     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc05-1973     Document Type: Review

References (46)

1. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
2. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD: Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 21:1230-1235, 1998
3. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S: Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 19:48-52, 1996
4. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M: Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol 127:135-144, 1988
5. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884-1890, 2003
6. Tull ES, Roseman JM: Diabetes in African Americans. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Bethesda, MD, National Institutes of Health, 1995, p. 613-630
7. Young BA, Maynard C, Boyko EJ: Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26:2392-2399, 2003
8. Young BA, Pugh JA, Maynard C, Reiber G: Diabetes and renal disease in veterans. Diabetes Care 27(Suppl. 2):B45-B49, 2004
9. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV: Ethnic disparities in diabetic complications in an insured population. JAMA 287:2519-2527, 2002
10. The UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
11. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
12. Gary TL, McGuire M, McCauley J, Brancati FL: Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization. Dis Manag 7:25-34, 2004
13. Rhee MK, Cook CB, Dunbar VG, Panayioto RM, Berkowitz KJ, Boyd B, George CD, Lyles RH, El-Kebbi IM, Phillips LS: Limited health care access impairs glycemic control in low income urban African Americans with type 2 diabetes. J Health Care Poor Underserved 16:734-746, 2005
14. Killilea T: Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 8:S441-S449, 2002
15. Briesacher B, Limcangco R, Gaskin D: Racial and ethnic disparities in prescription coverage and medication use. Health Care Financ Rev 25:63-76, 2003
16. Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC, Narayan KMV: A qualitative review of studies of diabetes preventive care among minority patients in the United States, 1993-2003. Am J Man Care 11:349-360, 2005
17. Isaacs R: Ethical implications of ethnic disparities in chronic kidney disease and kidney transplantation. Adv Ren Replace Ther 11:55-58, 2004
18. Ofili E: Ethnic disparities in cardiovascular health. Ethn Dis 11:838-840, 2001
19. Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC Jr, Narayan KM: Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother 39:1489-1501, 2005
20. Bonds DE, Zaccaro DJ, Karter AJ, Selby JV, Saad M, Goff DC Jr: Ethnic and racial differences in diabetes care: the Insulin Resistance Atherosclerosis Study. Diabetes Care 26:1040-1046, 2003
21. Bell RA, Camacho F, Goonan K, Duren-Winfield V, Anderson RT, Konen JC, Goff DC Jr: Quality of diabetes care among low-income patients in North Carolina. Am J Prev Med 21:124-131, 2001
22. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403-408, 1999
23. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, Gary TL, Caputo DA, Waitzfelder B, Kim C, Beckles GL: Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 28:2864-2870, 2005
24. Martin TL, Selby JV, Zhang D: Physician and patient prevention practices in NIDDM in a large urban managed-care organization. Diabetes Care 18:1124-1132, 1995
25. Maggs D, Shen L, Strobel S, Brown D, Kolterman O, Weyer C: Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis. Metabolism 52:1638-1642, 2003
26. Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA: Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care 21:510-515, 1998
27. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teutsch SM: Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol 47:1181-1189, 1994
28. Werk EE Jr, Gonzalez JJ, Ranney JE: Lipid level differences and hypertension effect in blacks and whites with type II diabetes. Ethn Dis 3:242-249, 1993
29. Wisdom K, Fryzek JP, Havstad SL, Anderson RM, Dreiling MC, Tilley BC: Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement: findings from a large urban health maintenance organization. Diabetes Care 20:971-977, 1997
30. Wing RR, Anglin K: Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care 19:409-413, 1996
31. de Rekeneire N, Rooks RN, Simonsick EM, Shorr RI, Kuller LH, Schwartz AV, Harris TB: Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition study. Diabetes Care 26:1986-1992, 2003
32. Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL, El-Kebbi IM, Ziemer DC, Ernst KL, Dunbar VG, Phillips LS: The pattern of dyslipidemia among urban African-Americans with type 2 diabetes. Diabetes Care 23:319-324, 2000
33. Sharma MD, Pavlik VN: Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab 3:41-45, 2001
34. Summerson JH, Bell RA, Konen JC: Coronary heart disease risk factors in black and white patients with noninsulin-dependent diabetes mellitus. Ethn Health 1:9-20, 1996
35. Weatherspoon LJ, Kumanyika SK, Ludlow R, Schatz D: Glycemic control in a sample of black and white clinic patients with NIDDM. Diabetes Care 17:1148-1153, 1994
36. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ: Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 353:692-700, 2005
37. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
38. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB: Tests of glycemia in diabetes. Diabetes Care 27:1761-1773, 2004
39. Jeffcoate SL: Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 21:657-665, 2004
40. Bry L, Chen PC, Sacks DB: Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47:153-163, 2001
41. Egede LE, Obah E, Lorch T, Oussova T: Spurious elevation of hemoglobin A1c by hereditary persistence of fetal hemoglobin. South Med J 93:62-64, 2000
42. Koskinen LK, Lahtela JT, Koivula TA: Fetal hemoglobin in diabetic patients. Diabetes Care 17:828-831, 1994
43. Carrasquillo O, Himmelstein DU, Woolhandler S, Bor DH: Going bare: trends in health insurance coverage, 1989 through 1996. Am J Public Health 89:36-42, 1999
44. Harris MI: Racial and ethnic differences in health insurance coverage for adults with diabetes. Diabetes Care 22:1679-1682, 1999
45. Sedlis SP, Fisher VJ, Tice D, Esposito R, Madmon L, Steinberg EH: Racial differences in performance of invasive cardiac procedures in a Department of Veterans Affairs Medical Center. J Clin Epidemiol 50:899-901, 1997
46. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM: The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med 341:1661-1669, 1999